in $ M
|1Net income attributable to Fresenius Medical Care AG & Co. KGaA.
2Before acquisitions and dividends.
32010: Proposal to be approved by the Annual General Meeting on May 12, 2011.
All figures in this report are stated in $ and in conformity with U.S. GAAP, if not indicated otherwise.
Unless specified, all charts refer to fiscal year 2010. For more details please look to the Five-year summary
|Selected key figures|
|Earnings before interest and taxes, depreciation and amortization (EBITDA)||2,427||2,213||10%|
|Ergebnis vor Zinsen und Ertragsteuern (EBIT)||1,924||1,756||10%|
|Net cash flow from operating activities||1,368||1,339||2%|
|Free cash flow2||861||777||11%|
|Capital expenditure, net||507||562||– 10%|
|Acquisitions, investments and purchases of intangible assets, net||6'8||136||354%|
|Earnings per ordinary share||3.25||2.99||9%|
|Dividend per ordinary share3||0.65||0.61||7%|
|Return on invested capital (ROIC)||8.8||8.5||—|
|Equity to assets||44.0||43.0||—|
|Employees (full-time equivalents)||73,452||67,988||8%|